CLINICAL STUDIES

Systematic Lupus Erythematosus (SLE) Study

A randomized, double-blind, phase 1b/2 combined, staggered multiple dose escalation study of BOS161721 in systematic lupus erythematosus (SLE) patients on a background of limited standard of care.

Study Phase:

Phase 1b/2

Criteria:

  • Men or Women, ages 18-70 years
  • Diagnosed with SLE
  • SLEBAI-2K more than 6
Register